Lumida
/BBNX
⌘K
Beta Bionics Inc

Beta Bionics Inc

BBNX
$16.57USD-0.12%-0.02 today

MARKET CAP

745.5M

P/E (TTM)

FWD P/E

DAY RANGE

$16 – $17

52W RANGE

$9
$33

AI Summary

Stalk
StalkMedium

BBNX remains in a Stage 2 uptrend with successive higher highs and higher lows above rising EMAs. The medium-term bias is bullish, but short-term price is extended above EMAs and in extreme overbought RSI territory, warranting patience. Preferred entries are on pullbacks into the 9- and 20-day EMA support zone for continuation participation.

  • Net sales grew 38% YoY to $32M in Q2 2026, led by new patient starts
  • Pharmacy channel now reimburses ~37–39% of patient starts, lowering costs
  • Operating expenses jumped 37% YoY to $44.5M, pressuring profitability
Full analysis →
Insider Trades42 trades
DateSideTickerInsiderRoleSharesPriceMkt Cap52W High52W LowValue% ChgRuleAI View
Jun 26, 2026SellBBNXStephen FeiderChief Financial Officer19,878$11.11$745.5M-49.34%+88.30%$220.8K-0.02%10b5-1Stalk
Jun 26, 2026SellBBNXStephen FeiderChief Financial Officer20,000$11.07$745.5M-49.34%+88.30%$221.4K+0.00%10b5-1Stalk
Jun 24, 2026SellBBNXMark HopmanChief Commercial Officer1,258$15.01$745.5M-49.34%+88.30%$18.9K-0.96%10b5-1Stalk
Jun 4, 2026SellBBNXMark HopmanChief Commercial Officer275$12.31$745.5M-49.34%+88.30%$3.4K-0.21%10b5-1Stalk
Jun 2, 2026SellBBNXSteven Jon RussellChief Medical Officer4,222$12.61$745.5M-49.34%+88.30%$53.2K-2.37%Stalk
Jun 2, 2026SellBBNXMike MensingerChief Product Officer4,378$12.61$745.5M-49.34%+88.30%$55.2K-2.32%Stalk
Jun 2, 2026SellBBNXMark HopmanChief Commercial Officer5,329$12.61$745.5M-49.34%+88.30%$67.2K-3.91%Stalk
Jun 2, 2026SellBBNXStephen FeiderChief Financial Officer6,676$12.61$745.5M-49.34%+88.30%$84.2K-3.87%Stalk
Jun 2, 2026SellBBNXSean SaintPresident & CEO16,872$12.61$745.5M-49.34%+88.30%$212.7K-3.85%Stalk
Mar 4, 2026SellBBNXMark HopmanChief Commercial Officer353$11.57$745.5M-49.34%+88.30%$4.1K-0.25%10b5-1Stalk
Mar 2, 2026SellBBNXMark HopmanChief Commercial Officer834$12.36$745.5M-49.34%+88.30%$10.3K-0.42%Stalk
Mar 2, 2026SellBBNXSteven Jon RussellChief Medical Officer1,026$12.36$745.5M-49.34%+88.30%$12.7K-0.43%Stalk
Mar 2, 2026SellBBNXMike MensingerChief Product Officer1,064$12.36$745.5M-49.34%+88.30%$13.2K-0.43%Stalk
Mar 2, 2026SellBBNXStephen FeiderChief Financial Officer1,428$12.36$745.5M-49.34%+88.30%$17.7K-0.58%Stalk
Mar 2, 2026SellBBNXSean SaintPresident & CEO3,384$12.36$745.5M-49.34%+88.30%$41.8K-0.54%Stalk
Jan 6, 2026SellBBNXMike MensingerChief Product Officer2,200$30.10$745.5M-49.34%+88.30%$66.2K-2.65%10b5-1Stalk
Jan 2, 2026SellBBNXMike MensingerChief Product Officer7,800$29.61$745.5M-49.34%+88.30%$231.0K-4.47%10b5-1Stalk
Jan 2, 2026SellBBNXStephen FeiderChief Financial Officer40,000$17.32$745.5M-49.34%+88.30%$692.7K+0.00%10b5-1Stalk
Dec 2, 2025SellBBNXSteven Jon RussellChief Medical Officer1,025$29.34$745.5M-49.34%+88.30%$30.1K-0.57%Stalk
Dec 2, 2025SellBBNXMike MensingerChief Product Officer1,063$29.34$745.5M-49.34%+88.30%$31.2K-1.16%Stalk
Dec 2, 2025SellBBNXStephen FeiderChief Financial Officer1,427$29.34$745.5M-49.34%+88.30%$41.9K-3.24%Stalk
Dec 2, 2025SellBBNXMark HopmanChief Commercial Officer2,917$30.27$745.5M-49.34%+88.30%$88.3K-1.05%10b5-1Stalk
Dec 2, 2025SellBBNXSean SaintPresident & CEO3,278$29.34$745.5M-49.34%+88.30%$96.2K-3.24%Stalk
Oct 3, 2025SellBBNXStephen FeiderChief Financial Officer9,964$13.40$745.5M-49.34%+88.30%$133.5K+0.00%10b5-1Stalk
Oct 1, 2025SellBBNXStephen FeiderChief Financial Officer30,036$12.93$745.5M-49.34%+88.30%$388.4K+0.00%10b5-1Stalk
Sep 8, 2025SellBBNXStephen FeiderChief Financial Officer19,800$13.11$745.5M-49.34%+88.30%$259.6K+0.00%10b5-1Stalk
Sep 5, 2025SellBBNXStephen FeiderChief Financial Officer200$13.05$745.5M-49.34%+88.30%$2.6K+0.00%10b5-1Stalk
Sep 4, 2025SellBBNXMark HopmanChief Commercial Officer34,389$13.18$745.5M-49.34%+88.30%$453.3K-0.69%10b5-1Stalk
Sep 2, 2025SellBBNXMark HopmanChief Commercial Officer848$18.86$745.5M-49.34%+88.30%$16.0K-2.48%Stalk
Sep 2, 2025SellBBNXSteven Jon RussellChief Medical Officer1,015$18.86$745.5M-49.34%+88.30%$19.1K-1.41%Stalk
Sep 2, 2025SellBBNXMike MensingerChief Product Officer1,089$18.86$745.5M-49.34%+88.30%$20.5K-1.17%Stalk
Sep 2, 2025SellBBNXStephen FeiderChief Financial Officer1,462$18.86$745.5M-49.34%+88.30%$27.6K-3.21%Stalk
Sep 2, 2025SellBBNXSean SaintPresident & CEO3,359$18.86$745.5M-49.34%+88.30%$63.4K-3.21%Stalk
Aug 22, 2025SellBBNXStephen FeiderChief Financial Officer8,826$11.06$745.5M-49.34%+88.30%$97.6K+0.00%10b5-1Stalk
Aug 19, 2025SellBBNXStephen FeiderChief Financial Officer11,174$11.07$745.5M-49.34%+88.30%$123.7K+0.00%10b5-1Stalk
Aug 19, 2025SellBBNXMark HopmanChief Commercial Officer32,316$10.85$745.5M-49.34%+88.30%$350.8K+0.00%10b5-1Stalk
Jun 2, 2025SellBBNXMark HopmanChief Commercial Officer868$17.89$745.5M-49.34%+88.30%$15.5K-0.83%Stalk
Jun 2, 2025SellBBNXSteven Jon RussellChief Medical Officer1,039$17.89$745.5M-49.34%+88.30%$18.6K-0.48%Stalk
Jun 2, 2025SellBBNXMike MensingerChief Product Officer1,115$17.89$745.5M-49.34%+88.30%$19.9K-0.40%Stalk
Jun 2, 2025SellBBNXStephen FeiderChief Financial Officer1,497$17.89$745.5M-49.34%+88.30%$26.8K-1.08%Stalk
Jun 2, 2025SellBBNXSean SaintPresident & CEO3,439$17.89$745.5M-49.34%+88.30%$61.5K-1.07%Stalk
Jan 31, 2025BuyBBNXMike MensingerChief Product Officer43,938$12.91$745.5M-49.34%+88.30%$567.4K+10.36%Stalk